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Abstract
Background: The impact on health related quality of life (HRQL) has been well studied in children with Immunoglobulin
E (IgE)-mediated food allergy. However limited data exists on related quality of life (QOL) of families who have a
child suffering from food protein induced non-IgE mediated gastrointestinal allergies. We aimed to establish the
QOL of families with children at the beginning of following an elimination diet for non-IgE mediated
gastrointestinal food allergies.
Methods: A prospective, observational study was performed. Parents of children aged 4 weeks–16 years who
improved after 4–8 weeks of following an elimination diet for suspected non-IgE mediated allergies were
included. The Family Impact Module (FIM) of the Pediatric Quality of Life (PedsQL™) was used and we compared
our data to two historical cohorts: one with sickle cell disease and another with intestinal failure.
Results: One hundred and twenty three children with a median age of 20 months were included (84 boys).
The total FIM Score was 57.43 (SD 22.27) and particularly low for daily activities and worry. Factors that impacted
significantly included age (p < 0.0001), number of foods excluded (p = 0.008), symptom severity (p = 0.041) and
chronic nasal congestion (p = 0.012). Children with non-IgE mediated food allergies had worse scores in all
domains (p < 0.0001) compared to sickle cell disease and worse physical (p = 0.04), emotional (p = 0.04) and worry
(p = 0.01) domains compared to intestinal failure.
Conclusions: This study found that parent QOL and family functioning was worse in those families who had a
child on an elimination diet for non-IgE mediated allergies compared to those with sickle cell disease and
intestinal failure, highlighting the impact this disease has on families.
Keywords: Non-IgE mediated allergies, Gastrointestinal allergies, Quality of life, Family impact score
Background
The prevalence of food allergy in children ranges be-
tween 3 and 7%, with the majority of allergies caused by
cow’s milk, hen’s egg, soya bean, wheat, peanut, tree
nuts, fish and shellfish [1–3]. Current nomenclature
classifies food allergies as either Immunoglobulin E (IgE)
mediated, non-IgE or a mix of IgE and non-IgE medi-
ated [4]. Food allergies affecting the gastrointestinal tract
are mainly non-IgE mediated, but can also present with
mixed symptoms. The most common reported symp-
toms include: diarrhoea, constipation, vomiting, severe
abdominal pain, feeding difficulties and growth faltering
[5]. In addition to the gastrointestinal symptoms, extra-
intestinal manifestations including joint pain, lethargy
and also severe sleep disturbances due to abdominal
discomfort, are common [6]. The combination of afore-
mentioned symptoms in addition to the burden and
cost of the elimination diet may impact significantly on
family life [7].
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The impact on health related quality of life (HRQL) in
children suffering from IgE-mediated food allergies and
its effect on their families has been well studied [8–10].
Primeau et al. [11] indicated significantly more dis-
ruption in the familial/social dimension in families with
a peanut allergic child, compared to parents of children
with rheumatological disease. Similarly Sicherer et al.
[12] also found an increase in emotional impact on par-
ents and limitation on family activities in their cohort
of IgE-mediated food allergic children. Particular
mothers seem to be affected with higher levels of stress
and anxiety [13]. In 2014 the European Academy for
Allergy and Clinical Immunology (EAACI) published a
position statement guiding the use of HRQL question-
naires in food allergic patients and their families [8].
The Food Allergy Quality of Life – Parent Burden ques-
tionnaire has been validated for IgE mediated, but not
for non-IgE mediated allergies affecting the gastrointes-
tinal tract [14]. The EAACI position statement highlighted
the fact that there were only validated disease specific
HRQL and family burden assessment tools for IgE-
mediated food allergies and that there was a need for
further studies to establish the burden of non-IgE me-
diated allergies and to develop new questionnaires. To
date, the only data published on the family burden in
non-IgE mediated allergies is the study by Klinnert
et al. [7] on families with children with Eosinophilic
Oesophagitis (EoE), a mixed non-IgE and IgE-mediated
condition and Greenhawt et al. on Food Protein
Induced Enterocolitis Syndrome (FPIES) [15]. Both
studies indicated a significant impact on daily function-
ing of families in a variety of domains [7, 15]. Studies
have also shown that having a child with chronic
gastrointestinal pain or inflammatory bowel disease im-
pacts significantly on family life [16, 17]. Limited data
exists on the family impact of the whole spectrum of
protein induced gastrointestinal non-IgE mediated
allergies, which comprises a variety of diagnoses includ-
ing proctocolitis, food protein enterocolitis syndrome,
food protein induced dysmotlity, enteropathy and eo-
sinophilic gastrointestinal disease. In our experience, it
is in particular the initial period following diagnosis,
where the burden is greatest on families. We therefore
set out to establish the QOL of families with children
at the beginning of following an elimination diet for
non-IgE mediated gastrointestinal food allergies. We
hypothesized that the families QoL would be much




A prospective, observational study was performed at the
tertiary gastroenterology department, from Great Ormond
Street Hospital for Children NHS Foundation Trust,
London, United Kingdom (UK). Ethical approval was ob-
tained for this study (Nr 11/LO/1177) from the NRES
London-Bloomsbury Committee and only children with
parental consent took part in this research project. Parents
of children aged 4 weeks – 16 years without non-allergic
co-morbidities (i.e., cerebral palsy, cardiac disorders) who
were required to follow an elimination diet for the diagno-
sis of suspected non-IgE mediated food protein induced
gastrointestinal allergies were approached for the study.
The foods chosen for elimination was individualised,
based on an allergy focused history performed by the
gastroenterologist and also considered the success/failure
of any previously eliminated foods. The elimination diet
was managed by a specialist paediatric allergy dietitian,
using the standard British Dietetic Association Diet sheets
for specific food allergens. As we wanted to capture
quality of life early at diagnosis, the inclusion in the
study occurred if, after 4–8 weeks of following the
elimination diet, there was an improvement in their
gastrointestinal symptoms. This was measured by a re-
peated Likert scale gastrointestinal symptom question-
naire that has previously been published [18]. Children
for this study were classified as non-IgE mediated al-
lergy based on the success of the elimination diet and
not on endoscopic evidence, as the majority did not
undergo an endoscopic procedure, which is not routine
practice in the UK. We also did not classify children
into categories of food protein induced enteropathy,
food protein induced enterocolitis syndrome, food aller-
gic dysmotility or proctocolitis as in the first 4–8 weeks
diagnosis is still established and the groups would be
too small for statistical sub-analysis. We also collected
data on atopic co-morbidities, including asthma, hayfever,
atopic dermatitis and have included nasal congestion
under this category, as our previously published work
showed this a common complaint from parents [5].
We used the Family Impact Module of the Pediatric
Quality of Life (PedsQl™) published by Varni et al.
[19], that has been designed for use both as an adjunct
to the existing PedsQL™ measurement scores or as a
standalone assessment tool from 2 to 18 years of age.
Permissions had been granted for the study to use this
questionnaire from the Mapi research trust (http://
www.mapi-trust.org/). The PedsQL Family Impact
Module™ (FIM) [Version 2] questionnaire has been
validated to measure impact for families with chil-
dren ≥ 2 year of age. Although children in our allergic
cohort were expected to be younger than 2 years of
age, many previous studies have used the FIM in youn-
ger cohorts, including the publication by Sanchez et al.
[20] that we used as historical control for this study
[20–23]. In addition, using this module enabled us to
compare our data to other cohorts. The FIM consists
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of 36 questions grouped into sections of Physical
Functioning, Emotional Functioning, Social Function-
ing, Cognitive Functioning, Communication, Worry,
Daily Activities and Family Relationships. Parents an-
swered the questions on a 5 score Likert scale (0–4)
where 0 means: “it is never a problem” and 4 means “it
is almost always a problem”. Each score was then
transformed into 0–100 scale in a following way: 4 = 0,
3 = 25, 2 = 50, 1 = 75, 0 = 100. If a parent scored more
than half of questions in a section then an average
score was calculated accounting for missing data.
Average score of all questions represents Total Score.
Parent QOL Summary Score is an average of scores
from Physical, Emotional, Social, and Cognitive Function-
ing sections. Family Summary Score is an average of
scores from Daily Activities and Family Relationships.
There are no cut-off values set for what is interpreted
as “poor” QOL for families as reply to questions are sub-
jective and depend on parental perception of their QOL.
However, for the purpose of the study, all patients that
had a PedsQL FIM™ score < 30 were contacted by the re-
searchers and offered additional support.
Parents were sent the PedsQL FIM™ questionnaire and
the research nurse assessed that all questions were com-
pleted at the time of the research appointment, which
occurred 4–12 weeks after commencing the elimination
diet. We compared our data to two historical control
groups that fit the criteria of a chronic health related
problem [22]. We obtained permission from Panepinto
et al. [24] to use group mean scores from their PedsQL
FIM™ from children with sickle cell disease (45.5% mild
and 54.5% severe disease). Similarly, using the same
questionnaire, we compared our results to those with in-
testinal failure (average bowel length 30 cm ±24) pub-
lished by Sanchez et al. [20]. These two groups were
chosen primarily because of available data using the
same PedsQL FIM™ and because sickle cell disease rep-
resented a chronic disorder with milder symptoms
whereas the children with intestinal failure were paren-
teral/enteral nutrition dependent with chronic symp-
toms and therefore embodied the severest end of
spectrum of gastrointestinal disease.
Statistical analysis
Descriptive statistics and logistic regression were done
in IBM SPSS Statistics for Windows, Version 22
(Armonk, NY) and t-tests were done in R version 3.0.3
(R Foundation for Statistical Computing, Vienna,
Austria). Two sided t-test was used to compare PedsQL
FIM™ mean scores between food allergic group and
sickle cell disease group. The same statistical technique
was used to compare the intestinal failure to the allergic
group, but we matched the ages and used only data of
children < 7 years as Sanches et al. [20] only included
children below this age (in three categories 1–12
months, 13–24 months and 2–6 year). A multiple linear
regression model was used to assess the relationships be-
tween PedsQL FIM Total Score and number of foods
excluded, the gastrointestinal symptoms score (taken
from Likert scale questionnaires after 4–8 weeks from
beginning of the elimination diet) and atopic features
accounted for age (in years) and gender. Only variables
which were significant were included in the model. Sig-
nificance level was set to 0.05.
Results
We identified 252 children with suspected non-IgE me-
diated gastrointestinal food allergies between December
2011 and November 2013 that were eligible for inclu-
sion in the study. Ninety-one patients were excluded
because they did not want to partake in the study, were
unable to attend/not reachable or had non-atopic co-
morbidities. Therefore 161 children were enrolled in
the study, of which 30 patients did not improve on the
elimination diet and consequently were excluded. Eight
parents did not complete the PedsQL FIM™, therefore
we analyzed questionnaires of 122 children. This cohort
included 84 boys (68.3%) and the median age of the
whole cohort was 20 months [IQR: 9 to 67.5]. Table 1
summarises the patient demographics, including the
number and type of elimination diets implemented.
The majority of children were on multiple exclusions,
with milk, egg, wheat and soya being the most common
combination. Gastrointestinal symptoms and the im-
provement of symptoms following the elimination diet
have been reported in a previous publication [18]. In
addition, 86% had at least one atopic co-morbidity, with
persistent nasal congestion being the most commonly
reported.
In 111 (90.2%) of subjects, the mother filled in the
questionnaire and 3 (2.4%) were completed by fathers.
In 9 (7.3%) cases, parents did not indicate who was fill-
ing in the questionnaire. Due to the small number of
fathers completing the questionnaire, we were not able
to perform any statistical analysis on the differences in
perceived QOL of the family between parents. The total
average PedsQL FIM™ Score was 57.43 (SD 22.27) and
while all domains indicated a poor QOL the impact of
non-IgE mediated food allergies seemed to particularly
affect daily family activities most and parents were very
worried (Table 2).
Multiple linear regression analysis was performed to
ascertain the impact on families QOL (Total Average)
of the following factors: gender, age, number of foods
excluded, atopic co-morbidities (asthma, eczema and
nasal congestion), persistent nasal congestion and
gastrointestinal symptoms (individual and total score of
symptoms) present after dietary elimination. The
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factors that impacted significantly (p < 0.05) on the
families QoL included age (p < 0.0001), number of
foods excluded (p = 0.008), total symptom score (p =
0.041) and nasal congestion (p = 0.012); implying that
the higher number of foods excluded, the higher
symptom severity, the younger age and the presence of
nasal congestion negatively impacted QoL of families.
When comparing the family impact on QOL between
our cohort and the patient group with sickle cell disease,
we found that children with non-IgE mediated food al-
lergies had worse scores in all domains. The difference
was greatest in emotional and cognitive functioning and
daily activities (Table 3). Similarly, when comparing our
cohort to children with intestinal failure, we found that
in all domains the mean score was lower in children
with non-IgE mediated food allergy, but only the phys-
ical, emotional and worry domains achieved statistical
difference (Table 4).
Discussion
This study sets out to establish the impact of QOL on
families with children who have non-IgE mediated food
allergies affecting the gastrointestinal tract based on an
elimination diet with symptoms improvement. The study
aimed to capture the early impact of this food allergy on
the QoL of families, who have often waited for months
for a diagnosis.
In this study, we found that the average total PedsQL
FIM™ score was worse than both intestinal failure and
sickle cell disease. Our data indicates that families in our
cohort are particularly affected in daily activities as well
as physical and emotional functioning. Additionally the
parents report significant worry about their child.
Sources of stress for families of healthy children include
the difficulties of feeding young babies, sleep issues, in-
fant crying and social isolation [25–27]. Many of these
aforementioned stresses are also experienced by parents
of children with non-IgE mediated allergies, in addition
to children struggling with sleep due to abdominal pain
and feeding difficulties [28, 29]. The poor physical and
emotional functioning of parents of children with non-
IgE mediated allergies often starts with poor symptom
recognition and delay in diagnosis [30], and when diag-
nosed, symptom management can often impose further
stress. The mainstay for treatment for this allergy is an
elimination diet that needs to be monitored and strictly
adhered to. The fear of accidental exposure and there-
fore the burden of planning meals, sourcing free-from
foods, ensuring that foods are not contaminated and
often trusting others to keep to the dietary elimination,
is significant [29]. Although this allergy is non-IgE medi-
ated and parents do not need to worry about anaphyl-
axis, an inadvertent exposure to an offending allergen
can lead to worsening of symptoms that can take a
couple of days to weeks to improve [18]. Similar areas,
affecting functioning of families of children with other
chronic diseases, including diabetes and cancer have also
been documented [22, 30].
Table 1 Patient demographics
Variable Data
Number of patients 123
Gender 84 boys (68.3%)
38 girls (31.7%)
Age 20 month [IQR: 9 to 67.5]







HF Only 14 (11.4%)
MES or MES+ 11 (9%)
MEWS or MEWS+ 33 (26.8%)






Allergic Rhinitis 25/122 (20%)
Nasal congestion 85/122 (70%)
At least one atopic feature 105/122 (86%)
aHF – hypoallergenic formula, MES – milk, egg soya, MEWS – milk, egg, soya,
wheat, MS – milk, soya
Table 2 FIM in children with non-IgE mediated food allergy on
QoL in different domains
Number Mean Std. Deviation
Total Score 123 57.43 22.27
Parent QoL 123 58.95 23.25
Family Functioning 122 57.96 25.26
Physical Functioning 122 55.43 26.89
Emotional Functioning 123 55.72 24.13
Social Functioning 123 62.21 27.72
Cognitive Functioning 121 63.33 24.57
Communication 123 58.54 29.15
Worry 123 50.17 24.33
Daily Activities 122 48.84 31.84
Family Relationships 121 63.43 26.01
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Worry is a common emotion documented in particular
in families of children with IgE mediated peanut allergy,
due to the fear of their child dying [9, 11]. From our study,
we do not know the exact reasons for the increased worry,
but in EoE the worry is specifically related to medical
management, problems with adherence to the diet, having
diarrhoea/vomiting in front of other children and long
term uncertain prognosis [31]. In the QoL study on FPIES,
parents scored in particular high on concerns about nutri-
tion, meal preparations, the child’s health and others not
appreciating the severity of reactions [15]. In addition to
this, we suspect that parents worry about the uncertain
prognosis and often express their concern about their
child deteriorating to where they were before the diagno-
sis/elimination diet and also the long term impact of
medication used for management. In particular, mothers
seem to be more affected when their child has a chronic
disease. Greene [32] indicated that mothers of children
with recurrent abdominal pain displayed greater anxiety,
depression and somatization, which was also found in
mothers of peanut allergic children [9]. Ninety-percent of
our questionnaires were filled in by the mothers and we
can therefore not rule out that perception of family impact
is worse for the mothers than the fathers also in non-IgE
mediated gastrointestinal allergies.
We have also found that the more foods that are elimi-
nated the worse the impact on family QOL. This is not sur-
prising at all, as the more foods are eliminated the more
limited the commercial food choices are resulting in an in-
creased need for home prepared foods. This also has a sig-
nificant impact on social activities for both the child and
the parent (i.e., what they can eat at a birthday party and
eating out), in addition to the emotional well-being [31].
In 86% of our cohort, at least one co-morbidity (i.e.,
asthma, eczema, rhinitis and chronic nasal congestion)
was present, which can impact on QOL irrespective of
the presence of food allergy. Using regression analysis,
we found that chronic nasal congestion was the only co-
Table 3 QoL differences between children with Sickle Cell Disease and Non-IgE mediated allergy
Sickle cell disease cohort Non-IgE mediated Cohort Mean difference Statistical significance
Mean Std. Deviation Mean Std. Deviation Between cohorts p value
FIM Total Score 73.2768 18.39831 57.43 22.27 −15.8468 <0.0001
FIM Parent QOL 73.9996 18.70280 58.95 23.25 −15.0496 <0.0001
FIM Family Functioning 74.3541 22.25948 57.96 25.26 −16.3941 <0.0001
Physical Functioning 66.8246 22.96708 55.43 26.89 −11.3946 0.0011
Emotional Functioning 75.6744 20.96464 55.72 24.13 −19.9544 <0.0001
Social Functioning 80.2517 23.16745 62.21 27.72 −18.0417 <0.0001
Cognitive Functioning 76.0460 23.02157 63.33 24.57 −12.7160 0.0001
Communication 77.5709 23.72894 58.54 29.15 −19.0309 <0.0001
Worry 65.7270 26.32828 50.17 24.33 −15.5570 <0.0001
Daily Activities 69.7133 26.80064 48.84 31.84 −20.8733 <0.0001
Family Relationships 77.3271 23.67000 63.43 26.01 −13.8971 0.0001
Table 4 QoL differences between children with intestinal failure and non-IgE mediated allergy
Intestinal failure Non-IgE mediated cohort Between cohorts Statistical significance
Mean St Dev n Mean mean difference p value
TOTAL Average 61.3 17.32 100 53.92 21.86 −7.38 0.1332
Average QoL 63.48 15.64 100 55.07 22.58 −8.41 0.0931
Physical 62.34 17.83 99 50.56 25.79 −11.78 0.0401*
Emotional 64.13 19.23 100 53.05 23.98 −11.08 0.0409*
Social 60.05 26.96 100 57.96 27.63 −2.09 0.7431
Cognitive 66.96 21.78 100 60.13 24.26 −6.83 0.2176
Communication 64.49 26.97 100 54.08 28.17 −10.41 0.1099
Worry 61.74 21.25 100 47.91 24.3 −13.83 0.0132*
FAMILY Average 57.61 20.09 99 54.95 25.76 −2.66 0.6442
Daily Activities 46.38 29.92 99 44.02 31.36 −2.36 0.7436
Family Relationships 64.35 20.69 98 61.53 27.18 −2.82 0.6419
* p < 0.05
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morbidity that significantly impacted on QOL. Eczema,
hayfever and asthma, where present did not impact on
the QoL of families. Interestingly nasal congestion has
been found in 72% of children < 2 years of age with cow’s
milk protein allergy in a study by Paddack et al. [33],
which is similar to our findings. Nasal congestion affects
both feeding coordination and sleep, both of which are
important for maintaining the QOL of families.
The study results also indicated that it is not one
symptom but the sum total of gastrointestinal symptoms
(including the perceived severity) that impacts family
QOL. Again this is not a surprising finding as studies on
EoE have found QOL correlates with the severity of
symptoms [7].
We hypothesised that the PedsQL FIM™ Score would
be worse in our cohort than children with other chronic
diseases [9, 10]. This hypothesis was proven correct in
all domains of QOL when comparing our data to fam-
ilies of children with sickle cell disease. In the sickle cell
cohort, 56% had severe sickle cell disease, but data on
management was not available. Parents of children with
this disease live in the fear of an acute sickle cell crisis,
that may present with a vaso-occlusive or haemolytic
crises affecting all organs and sepsis. However, patients
with sickle cell disease also develop frequent and recur-
rent painful episodes throughout life, that worsen with
age, thereby exhibiting chronic symptoms which are also
seen in young children with non-IgE mediated gastro-
intestinal food allergies [18]. Nevertheless we suspect
that the worse FIM scores of our non-IgE mediated co-
hort can be explained by the allergic group requiring a
food elimination diet [12], sleep being affected with on-
going symptoms and the uncertain prognosis as non-
IgE mediated gastrointestinal allergies remains poorly
understood. Rouf et al. [29] found that mothers with
food allergic children adjusted over time to develop
strategies to overcome the emotional and practical
challenges presented. However, in children with non-
IgE mediated gastrointestinal allergies, the goal post for
management and prognosis is constantly changing (i.e.,
can present with vomiting but then develop constipa-
tion later), thereby making it difficult to develop strat-
egies to overcome emotional challenges [34].
We also compared our cohort to a group of children
with intestinal failure aged between 6 months – 7 years
(mean age 2.3 years) that are stable and dependant on
either parenteral or enteral nutrition (56% had gastros-
tomies) [20]. The impact on families with artificial nu-
tritional support is significant, as it entails frequent
night-time feeding, concern about maintaining a sterile
environment to prevent often life threatening infections
and regularly requires procedures for re-inserting lines
and changing gastrostomies. Similar to our cohort, this
group would be dependent on optimal nutritional
management to control symptoms and social and fam-
ily life would be impaired due to the dependence on
artificial nutrition. Although intestinal failure repre-
sents an extreme gastrointestinal condition, we were
surprised to see that even compared to this group phys-
ical and emotional functioning, as well as worry about
their child as significantly lower. Although there are no
studies that explain this finding, we would hypothesise
that this may be related to the knowledge of progres-
sion in disease with intestinal failure, where healthcare
professionals understand the seriousness of the condi-
tion and there is a significant amount of research and
support associations to help families, which is not yet
the case for non-IgE mediated gastrointestinal allergies.
This study has several limitations. The first is related
to the PedsQL FIM™ questionnaire itself; that it is not
specific for families with children with non-IgE mediated
food allergies [8, 35, 36]. Although the FIM has been
used as means of assessing the impact on the family and
measurement of self-reported functioning in the family,
we are unable to assess the impact of the food allergy
itself. The advantage however to using this generic tool
is that we were able to compare this to other diseases
[37–39]. In addition, the PedsQL FIM™ has been vali-
dated for children 2–18 years of age and we have used
it in a younger cohort. Although this questionnaire has
been used by many studies in children < 2 years of age,
this limitation needs to be taken into account. It may
also be perceived as a limitation of the study that inclu-
sion of patients occurred based on symptom improve-
ment following an elimination diet, rather than a
formal challenge procedure. We wanted to establish
QoL of family early on as this is when we have ob-
served it to be the worst. All patients had subsequent
home reintroductions of foods, however if we waited
for these to occur, there would have been a delay of
several months and QoL improves with time. Another
limitation is the control groups, which were both his-
torical and therefore not specifically selected as a con-
trol group for this study. In addition significant age
differences exist between the sickle cell cohort and our
patient group, which may have biased the data. The
timing of completing the QOL questionnaire may also
be a limitation. Parents completed the questionnaire 4–
12 weeks after a successful elimination diet which may
have affected scoring as coping skills often improve
with time.
Strengths of this study include providing for the first
time an indication of the burden for families of children
with non-IgE mediated gastrointestinal allergies compared
to other chronic diseases. It also highlights the specific do-
mains of concern for families, namely worry, physical and
emotional functioning. This knowledge can already impact
on the advice and support given to families of children in
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the early stages of diagnosis when an elimination diet is
initiated, when it is likely to impact most.
Conclusion
This study has found that the QoL of parents and family
functioning was worse in children on an elimination diet
for non-IgE mediated gastrointestinal allergies compared
to sickle cell disease and they also had worse scores in
emotional and physical domains and worry than par-
ents/families of children with intestinal failure. We
found that the symptom severity, the number of foods
avoided and also the presence of chronic nasal conges-
tion impacts on QoL of families. We have highlighted
with this study the impact this allergy has on families,
which may help to inform clinical services with putting
in place appropriate advice and support structures.
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